IPP Bureau
Covaxin well tolerated with no safety concerns: Lancet
By IPP Bureau - November 12, 2021
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
Solara Active Pharma Sciences PAT slides to Rs 29.71 cr in Q2FY22
By IPP Bureau - November 12, 2021
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
J.B Chemicals & Pharmaceuticals PAT at Rs 98 cr. in Q2FY22
By IPP Bureau - November 12, 2021
J. B. Chemicals & Pharmaceuticals Limited (JBCPL), announced its financial results for the second quarter ended 30th September, 2021
Alembic Pharma PAT at Rs 169.29 cr. in Q2FY22
By IPP Bureau - November 11, 2021
The Board of Directors of Alembic Pharmaceuticals have approved the unaudited consolidated financial results of the company for the period ended September 30, 2021.
Metropolis Healthcare PAT at Rs 58.26 cr in Q2FY22
By IPP Bureau - November 11, 2021
Metropolis Healthcare has reported consolidated financial results for the period ended September 30, 2021
Curadev Pharma partners with CMC Vellore for dengue research
By IPP Bureau - November 11, 2021
The company will provide the technical and financial resources to support the study
Hester Biosciences to acquire 50 % stake in Thrishool Exim, Tanzania
By IPP Bureau - November 11, 2021
The consideration for the acquisition is US $ 2.25 million
Sudeep Pharma ventures into nutrition
By IPP Bureau - November 11, 2021
Sudeep Nutrition will be a one-stop solution for food, beverage, nutraceuticals and nutritional product manufacturers
Clinical study shows ViroStop spray prevents Covid-19
By IPP Bureau - November 11, 2021
Evidence also shows better immune response to virus among users of spray
LifeCell Diagnostics expands newborn screening portfolio
By IPP Bureau - November 11, 2021
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
.png "Medtronic first to launch cryoballoon catheter in India")
Medtronic first to launch cryoballoon catheter in India
By IPP Bureau - November 10, 2021
Cryoballoon catheter ablation, a minimally invasive procedure, is one of the therapeutic modalities to manage Atrial fibrillation
Moderna seeks approval from EMA for its Covid-19 vaccine for children between 6-11 years
By IPP Bureau - November 10, 2021
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
US govt places additional order of 1.4 million courses of molnupiravir
By IPP Bureau - November 10, 2021
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
Lupin partners with Shaan to raise awareness on mental health
By IPP Bureau - November 10, 2021
Shaan’s hit song `Tanha Dil Tanha Safar relaunched
Pulmatrix resolves dispute with Cipla
By IPP Bureau - November 10, 2021
Cipla Technologies a subsidiary of Cipla and Pulmatrix had inked a definitive agreement for the co-development and commercialisation of Pulmazole.
